Inhibition or knockdown of EZH2 induces cell cycle arrest and autophagic cell death via MEK-ERK1/2 signaling pathway, contributing to VSMC loss and AD development, while EZH2 overexpression promotes proliferation and reduces autophagic cell death. Here, EZH2 is linked to Alzheimer disease.